Tlando (testosterone) Capsule

Drug Interactions

Dayvigo should not be taken with a strong or moderate CYP3A inducers as they could reduce its effectiveness. These include rifampin, carbamazepine, efavirenz, and etravirine.

Special Considerations

Special consideration should be given to patients with complex sleep behaviors such as sleep walking, patients with a compromised respiratory system, chronic depression, suicidal ideation, pregnancy, drug addiction and comorbid diagnosis

Potential Side Effects/Toxicities

Unusual drowsiness, generalized weakness and fatigue, sleep paralysis, somnambulism, allergic reactions, worsening depression or suicidal ideations.

Dayvigo

Nursing Indications

he nurse should ensure that the patient is well educated on the drug use, especially the dosage and the potential side effects.

The Nurse should also ensure patient safety by examining occupation,, sleep history and mental health of the patient fist.

Patient Assessment

The patient’s sleep disorder should be assessed as this drug can cause complex sleep disorders. The patient should also not be an operator of heavy machinery as the drug can cause drowsiness at work. The patient should not have a history of sleep paralysis of sleep walking as the drug can make them worse.

Special considerations.

Women who are pregnant should be given special consideration. The drug should not be prescribed to children. Drug addicts and people with liver impairment should be given special consideration too.

Side Effect management

The medication should be changed if serious side effects are experienced.

Regular users should undergo regular liver function tests to determine if it is being affected.

Patients who experience of exhibit signs of depression should cease using the drug.

The dosage should be at the minimum affective level to avoid overdose toxicity.

The medication should only be taken immediately before getting into bed.

The dosage and schedule given by the doctor in the prescription should always be strictly followed.

Patient Education

Patient should not be an addict and should not take alcohol.

Any episodes of sleep paralysis, muscle weakness or sleep activity should be reported promptly.

The patient can experience daytime sleepiness when using the drug, so caution should be taken to avoid causing accidents

Usage of he medication should be ceased immediately if once s the patient is pregnant.

Drug Description

Dayvigo is a lemborexant of the sedative-hypnotics class. It is an oral tablet whose dosage should not exceed 10mg

It can be co-administered with a CYP3A inhibitor

Dayvigo treats insomnia by blocking the binding sites of the wake promoting neuropeptides Orexin A and Orexin B, thereby suppressing wake drive causing drowsiness.